Medtronic (NYSE:MDT) today announced U.S. Food and Drug Administration approval of the latest product in its growing diabetes portfolio, the next generation iPro2 continuous glucose monitoring (CGM) ...
MILAN - February 5, 2016 - A retrospective analysis of the iPro2 Professional CGM from Medtronic plc (MDT), the global leader in medical technology, demonstrates that patients with type 2 diabetes ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved the Enlite sensor for use with Medtronic’s iPro2 Professional Continuous Glucose Monitoring ...
iPro2 Professional CGM with Enlite Provides Critical Link Between Glucose Variability and Lifestyle for Improved Diabetes Control DUBLIN - Sept. 1, 2016 - Medtronic plc (MDT), the global leader in ...
Leading medical devices player, Medtronic ( MDT) has received approval from the US Food and Drug Administration (FDA) for iPro2, a next generation Professional continuous glucose monitoring (CGM) ...
Medtronic, Inc. (NYSE:MDT) today announced the Food and Drug Administration (FDA) approval of iPro ® 2, a next generation Professional continuous glucose monitoring (CGM) system and the latest in a ...
Medtronic has selected Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc., as an exclusive distributor of selected diabetes products to primary care physicians (PCPs) in the U.S.
In a recent press release, Medtronic announced the availability of the updated iPro(TM)2 myLog app with FoodPrint(TM) Report. The iPro2 myLog app offers a simple way for clinics to import patients’ ...
Device giant Medtronic rolled out an updated meal-logging app for its iPro2 glucose-monitoring device that can be used by physicians and patients to help keep diabetes in check. The myLog app uses ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio The medical technology company Medtronic ...
Leading medical devices player, Medtronic (NYSE:MDT - News) has received approval from the US Food and Drug Administration (:FDA) for iPro2, a next generation Professional continuous glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results